Regenicin, Inc. (RGIN) has a market capitalization of $15.35K and trades at $0.00. The 52-week range is 0.0001-0.7501.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $0.00.
The stock has a beta of -2.27, operates in the Healthcare sector.
